USE OF 1-(2-CHLOROETHYL)-1-NITROSO-3-(2-HYDROXYETHYL)-UREA FOR THE TREATMENT OF PANCREATIC CANCER, SOFT-TISSUE SARCOMA, TESTICULAR TUMORS, LYMPHOMA, THYMOMA, WILM'S TUMORS, RENAL CARCINOMA, MELANOMA, LUNG CANCER, INTRACEREBRAL METASTASIS, TUMORS IN THE HEAD AND NECK REGION, AND MAMMARY CARCINOMA

摘要

The invention relates to the use of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)-urea (henceforth also called HECNU ) for the treatment of pancreatic cancer, soft-tissue sarcoma, testicular tumors, lymphoma, thymoma, Wilm's tumor, renal carcinoma, melanoma, lung cancer, intracerebral metastases, tumors in the head and neck region, and mammary carcinoma.